Antianxiety or Hypnotic Drug Use
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Antianxiety or hypnotic drug use
Numerator
Number of residents with antianxiety or hypnotic drug use. Residents receiving any type of these medications the last 7 days before assessment were considered to be using the medications.
Denominator
Number of residents
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
The assessment is conducted by nurses who have received standardised training in using the interRAI-MDS 2.0 and is based on observations, clinical documentation, and interviews with residents and their family members.
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Online at island.is/en/interrai-assessment/dashboard (in Icelandic)
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Gisladottir, S., Sigurdardottir, A. K., & Hjaltadottir, I. (2021). Use of psychiatric medication in three Arctic nursing homes: association with dementia and psychiatric symptoms. International journal of circumpolar health, 80(1), 1920252. island.is/en/interrai-assessment/dashboard
Technical Specifications
island.is/en/interrai-assessment/dashboard (in Icelandic)